Illumina Receives Approval of MiSeq™Dx System in China
Illumina,
Inc. (NASDAQ:ILMN) today announced that its MiSeq™Dx
Sequencing System received the approval certificate from the China
National Drug Administration (CNDA). This is Illumina’s first
CNDA-cleared, next-gene…
Illumina,
Inc. (NASDAQ:ILMN) today announced that its MiSeq™Dx
Sequencing System received the approval certificate from the China
National Drug Administration (CNDA). This is Illumina’s first
CNDA-cleared, next-generation ...